Identification of a Prognostic Immune Signature for Esophageal Squamous Cell Carcinoma to Predict Survival and Inflammatory Landscapes

Immunotherapy has achieved success in the treatment of esophageal squamous cell carcinoma (ESCC). However, studies concerning immune phenotypes within the ESCC microenvironment and their relationship with prognostic outcomes are limited. We constructed and validated an individual immune-related risk...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Chaoqi, Luo, Yuejun, Zhang, Zhen, Zhang, Zhihui, Zhang, Guochao, Wang, Feng, Che, Yun, Fang, Lingling, Zhang, Yi, Sun, Nan, He, Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Cell and Developmental Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7773787/
https://www.ncbi.nlm.nih.gov/pubmed/33392181
http://dx.doi.org/10.3389/fcell.2020.580005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7773787/
https://www.ncbi.nlm.nih.gov/pubmed/33392181
http://dx.doi.org/10.3389/fcell.2020.580005

Ejemplares similares